You are here

Emma Iles

Emma Iles


Emma is a Partner in the Intellectual Property Disputes team.



Emma is a specialist in intellectual property advice and dispute resolution. Emma advises clients in all areas of IP and technology, including patents, trade marks, copyright, plant breeder’s rights, consumer law and confidential information.

Her litigious experience includes multi-jurisdictional patent disputes, international arbitrations, trade mark, copyright and consumer law disputes, collaboration agreement disputes related to IP ownership, commercial damages disputes, mediations, preparation of technical expert evidence, trial and appeal proceedings. This experience extends to industries including pharmaceuticals, biotechnology, medical devices, software, and consumer products.

Emma also has considerable experience advising clients on regulatory issues relating to pharmaceuticals and medical devices.

In addition to her legal qualifications Emma holds a Biomedical Science degree. Emma brings her strong science background to her work, particularly in developing strategies and legal arguments around scientific subject matter and in dealing with experts across a variety of disciplines. 

Emma’s experience includes representing:

  • Gilead in patent infringement proceedings relating to a blockbuster HIV treatment
  • Boehringer Ingelheim in patent infringement and invalidity proceedings relating to threatened generic launch of inhalable formulations for use in the treatment of COPD (an area in which Boehringer is a global leader)
  • an international pharmaceutical company in an international arbitration relating to IP and patent rights over an IV antibiotic treatment arising from a collaboration agreement
  • an international originator biotechnology company in relation to the litigious strategy for future biosimilar launch
  • a pharmaceutical company in a number of pharmaceutical patent infringement cases in both the Federal Court and patent office, including one of the few cases to be heard by Australia’s High Court in recent years
  • Tibra Trading in litigation over whether Tibra’s algorithmic trading software had been developed by ex-employees of Optiver in a manner which infringed Optiver’s IP 




Emma completed her Bachelor of Laws (Honours) and Bachelor of Biomedical Science at Monash University. Emma also has a Masters of Commercial Law from Melbourne University.

She is admitted to practice in the Supreme Court of Victoria, the Federal Court of Australia and the High Court of Australia.

Market Recognition

Emma is recognised by Legal 500 as a Rising Star for Intellectual Property and by Chambers in Life Sciences as an Associate to watch. She is consistently recognised in Doyle’s Guide as a Rising Star and has been recognised as a ‘Best Lawyer’ for Intellectual Property (2021, 2022) and Alternative Dispute Resolution (2022).